Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wall

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 6, 2000, Pages 1452-1458

  Wen, Shan ^a,b   Schneider, Darren B ^a   Driscoll, Robert M ^a   Vassalli, Giuseppe ^a   Sassani, André B ^a   Dichek, David A ^a,b  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carotid arteries; Gene therapy; Inflammation; Rabbits; galactosidase

Indexed keywords

BETA GALACTOSIDASE; CYCLOPHOSPHAMIDE; GLYCOPROTEIN; VIRUS DNA; VIRUS VECTOR;

ADENOVIRUS 2; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; CHO CELL; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TEMPERATURE SENSITIVE MUTANT; TRANSGENE;

EID: 0034082167     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.6.1452     Document Type: Article

References (36)

1. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 1993;73:797-807.
2. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest. 1995;96:2955-2965.
3. Channon KM, Qian H, Youngblood SA, Olmez E, Shetty GA, Neplioueva V, Blazing MA, George SE. Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function. Circ Res. 1998;82: 1253-1262.
4. Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 1995;69:2004-2015.
5. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med. 1996;2: 545-550.
6. Dai Y, Schwarz EM, Gu D, Zhang W-W, Sarvetnick N, Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci U S A. 1995;92:1401-1405.
7. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci U S A. 1994; 91:6196-6200.
8. - adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther. 1995;2:256-262.
9. Kochanek S, Clemens PR, Mitani K, Chen H-H, Chan S, Caskey CT. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc Natl Acad Sci U S A. 1996;93:5731-5736.
10. Finkel T. Thinking globally, acting locally: the promise of cardiovascular gene therapy. Circ Res. 1999;84:1471-1472.
11. Vassalli G, Agah R, Qiao R, Aguilar C, Dichek DA. A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression. Circ Res. 1999;85:e25-e32.
12. Dong G, Schulick AH, DeYoung MB, Dichek DA. Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-β1 responsiveness in endothelium in vivo. J Biol Chem. 1996;271:29969-29977.
13. Wold WSM, Tollefson AE, Hermiston TW. E3 transcription unit of adenovirus. Curr Top Microbiol Immunol. 1995;199:237-274.
14. Ensinger MJ, Ginsberg HS. Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus. J Virol. 1972;10: 328-339.
15. Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, Pernis B, Wold WSM, Chanock RM, Prince GA. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci U S A. 1989;86: 3823-3827.
16. Kruijer W, van Schaik FMA, Sussenbach JS. Structure and organization of the gene coding for the DNA binding protein of adenovirus type 5. Nucleic Acids Res. 1981;9:4439-4457.
17. Schneider DB, Vassalli G, Wen S, Driscoll RM, Sassani AB, DeYoung MB, Linnemann R, Virmani R, Dichek DA. Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol. 2000;20:298-308.
18. Becker K, Pan D, Whitley CB. Real-time quantitative polymerase chain reaction to assess gene transfer. Hum Gene Ther. 1999;10:2559-2566.
19. Zar JH. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall; 1984.
20. Chen H-H, Mack LM, Choi S-Y, Ontell M, Kochanek S, Clemens PR. DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle. Hum Gene Ther. 1999;10:365-373.
21. Yang Y, Nunes FA, Berencsi K, Gönczöl E, Engelhardt JF, Wilson JM. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet. 1994;7:362-369.
22. Engelhardt JF, Litzky L, Wilson JM. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther. 1994;5:1217-1229.
23. Goldman MJ, Litzky LA, Engelhardt JF, Wilson JM. Transfer of the CFTR gene to the lung of nonhuman primates with El-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study. Hum Gene Ther. 1995;6:839-851.
24. Barr D, Tubb J, Ferguson D, Scaria A, Lieber A, Wilson C, Perkins J, Kay MA. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 1995;2: 151-155.
25. - recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther. 1996;3: 217-222.
26. Roessler BJ, Allen ED, Wilson JM, Hartman JW, Davidson BL. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest. 1993;92:1085-1092.
27. Michou AI, Santoro L, Christ M, Julliard V, Pavirani A, Mehtali M. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 1997;4:473-482.
28. Yang Y, Ertl HCJ, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity. 1994;1:433-442.
29. Wadsworth SC, Zhou H, Smith AE, Kaplan JM. Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo. J Virol. 1997;71:5189-5196.
30. Routes JM, Cook JL. Resistance of human cells to the adenovirus E3 effect on class I MHC antigen expression: implications for viral immunity. J Immunol. 1990;144:2763-2770.
31. Schowalter DB, Tubb JC, Liu M, Wilson CB, Kay MA. Heterologous expression of adenovirus E3-gp19K in an E1a deleted adenovirus vector inhibits MHC-I expression in vitro, but does not prolong transgene expression in vivo. Gene Ther. 1997;4:351-360.
32. Bruder JT, Jie T, McVey DL, Kovesdi I. Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver. J Virol. 1997;71:7623-7628.
33. Rawle FC, Tollefson AE, Wold WSM, Gooding LR. Mouse antiadenovirus cytotoxic T lymphocytes: inhibition of lysis by E3 gp19K but not E3 14.7K. J Immunol. 1989;143:2031-2037.
34. Worgall S, Wolff G, Falck-Pedersen E, Crystal RG. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther. 1997;8:37-44.
35. Schneider DB, Sassani AB, Vassalli G, Driscoll RM, Dichek DA. Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors. J Vasc Surg. 1999;29:543-550.
36. Guidotti LG, Chisari FV. Cytokine-induced viral purging: role in viral pathogenesis. Curr Opin Microbiol. 1999;2:388-391.